Paid Clinical Trials and Focus Groups by Category |
|
|
|
-
United Kingdom, England
United Kingdom
Are you healthy? Want to join a clinical trial?
We’re looking for volunteers from all walks of life but particularly people from the black community and
Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: NN9925 (oral); Drug: NN9925 (i.v.); Drug: placebo; Drug: NN9925 (oral); Drug: placebo
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Condition: Eyelid Diseases
Intervention: Device: LT2420
Sponsor: Laboratoires Thea
Not yet recruiting - verified March 2010
Conditions: Congenital FXIII Deficiency; Healthy
Interventions: Drug: recombinant factor XIII; Drug: recombinant factor XIII
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491)
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: granisetron IV; Drug: granisetron patch
Sponsor: Prostrakan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: AZD5069
Sponsors: AstraZeneca; Quintiles
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Dietary Intervention
Interventions: Dietary Supplement: probiotic; Dietary Supplement: prebiotic; Dietary Supplement: Synbiotic; Dietary Supplement: Placebo
Sponsor: University of Reading
Not yet recruiting - verified February 2010
Condition: Histamine Induced Itch
Interventions: Drug: A:JNJ-39758979/Placebo #1; Drug: B: JNJ-39758979 Matching Placebo /Placebo #2; Drug: C:Cetirizine/JNJ-39758979 Matching Placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Conditions: Major Depressive Disorder; Healthy Volunteers
Intervention: Drug: Duloxetine
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: AZD5069; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Healthy Volunteers
Interventions: Drug: losmapimod 1 mg; Drug: losmapimod; Drug: losmapimod 15 mg
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: NN9924 (oral); Drug: placebo; Drug: NN9924 (oral); Drug: placebo; Drug: NN9924 (s.c.); Drug: NN9924 (i.v.)
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: QTc Evaluation; Electrocardiography
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039); Drug: Placebo
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: AZD2423; Drug: Placebo; Drug: AZD2423; Drug: AZD2423; Drug: AZD2423
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Alzheimer's Disease
Interventions: Drug: AZD3480; Drug: AZD3480
Sponsor: AstraZeneca
Recruiting - verified March 2010